Sinha Vikas's Form 4/A amendment
AmendedVerona Pharma plcVRNA · filed May 22, 2025
- Accession no.
- 0001104659-25-051979
- Filed
- May 22, 2025
- Trade date
- Apr 29, 2025
- Filing delay
- 23 days
- Rule 10b5-1 plan
- Checked
- Original filed
- May 1, 2025
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.43M. It was filed 23 days after the trade.
This amendment replaces 0001104659-25-043644 (filed May 1, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinha VikasCIK 0001337845 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Ordinary Shares | MOption exerciseAcquired | +120,384 | $1.70 | +$204,652.8 | 194,824 | Direct | |
| Apr 29, 2025 | Ordinary Shares | SSaleDisposed | −120,384 | $8.92 | −$1,073,825.28 | 74,440 | Direct | |
| Apr 29, 2025 | Ordinary Shares | MOption exerciseAcquired | +39,616 | $0.50 | +$19,808 | 114,056 | Direct | |
| Apr 29, 2025 | Ordinary Shares | SSaleDisposed | −39,616 | $8.92 | −$353,374.72 | 74,440 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Ordinary Shares | MOption exerciseDisposed | −120,384 | $0.00 | $0 | 0 | Direct | |
| Apr 29, 2025 | Ordinary Shares | MOption exerciseDisposed | −39,616 | $0.00 | $0 | 160,384 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares ("ADSs") instead of Ordinary Shares.
- F2
Reported securities are represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer.
- F3
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price.
- F4
Consists of 74,440 Ordinary Shares represented by 9,305 ADSs.
- F5
The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer.
- F6
The option is fully vested.